Selumetinib: Assist Neurofibropathy Type I Patients In Reigniting The Flame Of Life

Selumetinib (INN) is sold under the trade name Koselugo and is a medication used to treat children aged 2 years and older with type I neurofibromatosis (NF-1). This drug provides a new treatment option for…











